The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
South East (England); Berkshire, Buckinghamshire and Oxfordshire; Berkshire East
Location of affected unit(s)
Bracknell
Sector
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
220 jobs Number of planned job losses
Announcement Date
11 October 2007
Employment effect (start)
1 October 2009
Foreseen end date
31 December 2010
Description
Boehringer Ingelheim UK, a firm that operates in the pharmaceutical sector and is a subsidiary of multi-national group Boehringer Ingelheim, is to cut 220 jobs in Bracknell. The firm’s site at Bracknell, at which 340 are employed, produces respiratory products in a specific form called Unit Dose Vials (UDVs). The job cuts are due to the firm’s decision to stop producing UDVs. A spokesman for the firm stated:
‘The reason the decision has been taken to phase out production is that in the future there will be no new products in UDV form coming from the Boehringer Ingelheim pipeline and the focus is now on new device technologies for respiratory products. Additionally, the current UDV products now face low priced competition meaning that it is not possible to compete given the company's production costs in Bracknell.’
The job cuts will not begin to be implemented until October 2009, and the restructuring is scheduled to be completed by 2010. Boehringer Ingelheim employs 1000 in the UK and 38,400 globally.
Sources
11 October 2007: BBC News
Citation
Eurofound (2007), Boehringer Ingelheim UK, Internal restructuring in United Kingdom, factsheet number 65917, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/65917.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
The more employee monitoring resembles surveillance – with its systematic, continuous and detailed tracking of employees' activities, behaviours or communications – the greater the potential for infringement of both privacy and data protection rights. Although the EU General Data Protection...
Since 2013, Eurofound's ERM database on restructuring-related legislation has been documenting regulatory developments in the Member States of the European Union and Norway which are explicitly or implicitly linked to anticipating and managing change. The most recent update to the...